- Home
- NTGR vs AVBP Comparison
NTGR vs AVBP Comparison
Compare NTGR & AVBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTGR
- AVBP
- Stock Information
- Founded
- NTGR 1996
- AVBP 2021
- Country
- NTGR United States
- AVBP United States
- Employees
- NTGR N/A
- AVBP N/A
- Industry
- NTGR Telecommunications Equipment
- AVBP
- Sector
- NTGR Utilities
- AVBP
- Exchange
- NTGR Nasdaq
- AVBP NYSE
- Market Cap
- NTGR 713.6M
- AVBP 617.4M
- IPO Year
- NTGR N/A
- AVBP 2024
- Fundamental
- Price
- NTGR $24.92
- AVBP $18.03
- Analyst Decision
- NTGR Buy
- AVBP Strong Buy
- Analyst Count
- NTGR 2
- AVBP 6
- Target Price
- NTGR $21.00
- AVBP $39.00
- AVG Volume (30 Days)
- NTGR 340.7K
- AVBP 184.7K
- Earning Date
- NTGR 04-30-2025
- AVBP 03-03-2025
- Dividend Yield
- NTGR N/A
- AVBP N/A
- EPS Growth
- NTGR N/A
- AVBP N/A
- EPS
- NTGR 0.42
- AVBP N/A
- Revenue
- NTGR $673,759,000.00
- AVBP N/A
- Revenue This Year
- NTGR $3.06
- AVBP $63.13
- Revenue Next Year
- NTGR $4.86
- AVBP N/A
- P/E Ratio
- NTGR $58.24
- AVBP N/A
- Revenue Growth
- NTGR N/A
- AVBP N/A
- 52 Week Low
- NTGR $10.48
- AVBP $14.35
- 52 Week High
- NTGR $31.55
- AVBP $36.37
- Technical
- Relative Strength Index (RSI)
- NTGR 50.23
- AVBP 27.29
- Support Level
- NTGR $24.03
- AVBP $17.89
- Resistance Level
- NTGR $25.13
- AVBP $19.04
- Average True Range (ATR)
- NTGR 0.84
- AVBP 1.04
- MACD
- NTGR 0.21
- AVBP -0.02
- Stochastic Oscillator
- NTGR 90.79
- AVBP 9.98
About NTGR NETGEAR Inc.
Netgear Inc is a provider of networking solutions. The reportable segments of the company are connected home, and Small and Medium Businesses (SMB). The Connected Home segment focuses on consumers and consists of high-performance, dependable, and easy-to-use 4G/5G mobile, Wi-Fi internet networking solutions, and smart devices such as Orbi Voice smart speakers and Meural digital canvas; and NETGEAR specializes in providing networking solutions for businesses, including wireless LAN, Pro AV applications for audio and video over Ethernet, security, and remote management.
About AVBP ARRIVENT BIOPHARMA INC
ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. It seeks to utilize the team's deep drug development experience to maximize the potential of the lead development candidate, furmonertinib, and advance a pipeline of novel therapeutics, such as next-generation antibody-drug conjugates, through approval and commercialization in patients suffering from cancer, with an initial focus on solid tumors.